
The European Commission’s competition authority has been pouring over a proposed concessions package from Aon, with the insurance and reinsurance broking giant saying it would offload a raft of businesses in order to gain approval for the merger with Willis Towers Watson (WTW).
The EC has been seeking feedback from competitors and potential buyers of divestment assets, including the Willis Re reinsurance broking arm of WTW, and the latest is that approval is likely to be given with only small tweaks needed to the remedy package offered.
Sources suggest news on divestment deals could come within days to a few weeks at most, which all points to the merger parties being ready to move forwards as soon as possible.
On the regulator side, though, the timeline may not be being seen as this clear-cut, with the EC having restarted the clock on its investigation into the proposed combination of the pair after concessions were submitted on April 9th, with the deadline for completion was extended to July 12, 2021, but then extended by a further 10 working days to July 27, 2021.
However, the EC’s competition and antitrust related unit has now extended the decision deadline again on Tuesday, May 4, pushing it back five more working days into August, with a final decision on the Aon and WTW merger now due by August 3, 2021.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas